1. Home
  2. HASI vs ALKS Comparison

HASI vs ALKS Comparison

Compare HASI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hannon Armstrong Sustainable Infrastructure Capital Inc.

HASI

Hannon Armstrong Sustainable Infrastructure Capital Inc.

HOLD

Current Price

$40.46

Market Cap

5.1B

Sector

Real Estate

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$33.50

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HASI
ALKS
Founded
1981
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.5B
IPO Year
2012
2012

Fundamental Metrics

Financial Performance
Metric
HASI
ALKS
Price
$40.46
$33.50
Analyst Decision
Buy
Buy
Analyst Count
7
14
Target Price
$43.57
$43.43
AVG Volume (30 Days)
675.4K
2.6M
Earning Date
05-07-2026
04-24-2026
Dividend Yield
4.18%
N/A
EPS Growth
N/A
N/A
EPS
1.41
1.43
Revenue
$400,502,000.00
$1,475,899,000.00
Revenue This Year
$394.10
$24.26
Revenue Next Year
$11.64
$4.47
P/E Ratio
$28.96
$23.86
Revenue Growth
4.41
N/A
52 Week Low
$24.19
$25.17
52 Week High
$41.15
$36.48

Technical Indicators

Market Signals
Indicator
HASI
ALKS
Relative Strength Index (RSI) 69.12 55.05
Support Level $35.18 $27.65
Resistance Level N/A $33.88
Average True Range (ATR) 0.90 1.17
MACD 0.25 -0.01
Stochastic Oscillator 77.37 25.69

Price Performance

Historical Comparison
HASI
ALKS

About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.

HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition. The company's single reportable segment generates net investment and equity method investment income through investments in energy transition assets and infrastructure projects, as well as revenue through the gain on sale of assets and recurring asset management fees.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: